Please use this identifier to cite or link to this item:
https://doi.org/10.1016/j.ijpharm.2007.04.031
DC Field | Value | |
---|---|---|
dc.title | Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy | |
dc.contributor.author | Dong, Y. | |
dc.contributor.author | Feng, S.-S. | |
dc.date.accessioned | 2014-10-09T06:58:07Z | |
dc.date.available | 2014-10-09T06:58:07Z | |
dc.date.issued | 2007-09-05 | |
dc.identifier.citation | Dong, Y., Feng, S.-S. (2007-09-05). Poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy. International Journal of Pharmaceutics 342 (1-2) : 208-214. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ijpharm.2007.04.031 | |
dc.identifier.issn | 03785173 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/89819 | |
dc.description.abstract | High pressure homogenization was employed in the current work to prepare poly(d,l-lactide-co-glycolide) (PLGA) nanoparticles (NPs) for controlled release of paclitaxel. The prepared drug-loaded PLGA NPs were found of spherical shape with a size of 200-300 nm. The drug encapsulation efficiency ranged from 34.8 ± 1.6 to 62.6 ± 7.9% depending on the homogenization pressure and cycles. Paclitaxel was released from the nanoparticles in a biphasic profile with a fast release rate in the first 3 days followed by a slow first-order release. A higher or comparable cytotoxicity against glioma C6 cells was found for the drug formulated in the PLGA NPs in comparison with the free drug Taxol®. Confocal laser scanning microscopy (CLSM) evidenced internalization of the fluorescent coumarin 6-loaded PLGA NPs by the C6 cells. The freeze-dried nanoparticles were found to possess excellent water redispersability. The high pressure homogenization could be applied for large industrial scale production of nanoparticles for drug delivery. © 2007 Elsevier B.V. All rights reserved. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ijpharm.2007.04.031 | |
dc.source | Scopus | |
dc.subject | Anticancer drugs | |
dc.subject | Cancer nanotechnology | |
dc.subject | Chemotherapeutic engineering | |
dc.subject | Nanobiotechnology | |
dc.subject | Nanomedicine | |
dc.subject | Paclitaxel | |
dc.type | Article | |
dc.contributor.department | CHEMICAL & BIOMOLECULAR ENGINEERING | |
dc.description.doi | 10.1016/j.ijpharm.2007.04.031 | |
dc.description.sourcetitle | International Journal of Pharmaceutics | |
dc.description.volume | 342 | |
dc.description.issue | 1-2 | |
dc.description.page | 208-214 | |
dc.description.coden | IJPHD | |
dc.identifier.isiut | 000249680400026 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.